1. Anti-infection
  2. Bacterial

Solithromycin (Synonyms: CEM-101; OP-1068)

Cat. No.: HY-17593 Purity: 99.81%
Data Sheet SDS Handling Instructions

Solithromycin is a novel fluoroketolide with improved antimicrobial effectiveness.

For research use only. We do not sell to patients.
Solithromycin Chemical Structure

Solithromycin Chemical Structure

CAS No. : 760981-83-7

Size Price Stock Quantity
Free sample   Apply now  
10 mM * 1 mL in DMSO $270 In-stock
2 mg $80 In-stock
5 mg $160 In-stock
10 mg $290 In-stock
50 mg $900 In-stock
100 mg   Get quote  
200 mg   Get quote  

* Please select Quantity before adding items.

Top Publications Citing Use of Products
  • Biological Activity

  • Protocol

  • Technical Information

  • Purity & Documentation

  • References

Description

Solithromycin is a novel fluoroketolide with improved antimicrobial effectiveness. Target: Antibacterial Solithromycin binds to the large 50S subunit of the ribosome and inhibits protein biosynthesis. The mean 50% inhibitory concentrations (IC50s) for Solithromycin inhibition of cell viability, protein synthesis, and growth rate were 7.5, 40, and 125 ng/ml for Streptococcus pneumoniae,Staphylococcus aureus, and Haemophilus influenzae, respectively.

Clinical Trial
NCT Number Sponsor Condition Start Date Phase
NCT01591447 Cempra Inc Uncomplicated Urogenital Gonorrhea May 2012 Phase 2
NCT01168713 Cempra Inc Community-Acquired Bacterial Pneumonia August 2010 Phase 2
NCT02348424 National Institute of Allergy and Infectious Diseases (NIAID) Gonorrhoea May 5, 2015 Phase 1
NCT02628769 Imperial College London|Cempra Inc Pulmonary Disease, Chronic Obstructive July 2015 Phase 2
NCT02605122 Cempra Inc|Biomedical Advanced Research and Development Authority Community-acquired Bacterial Pneumonia April 2016 Phase 2|Phase 3
NCT02268279 Cempra Inc|Department of Health and Human Services Bacterial Infection January 2015 Phase 1
NCT02510599 Cempra Inc Nonalcoholic Steatohepatitis December 2015 Phase 2
NCT02210325 Cempra Inc|National Institute of Allergy and Infectious Diseases (NIAID) Uncomplicated Urogenital Gonorrhea August 2014 Phase 3
NCT01966055 Cempra Inc|Department of Health and Human Services Bacterial Infections December 2013 Phase 1
NCT01968733 Cempra Inc Community-acquired Bacterial Pneumonia November 2013 Phase 3
NCT01756339 Cempra Inc Community-acquired Bacterial Pneumonia December 2012 Phase 3
View MoreCollapse
References
Preparing Stock Solutions
Concentration Volume (DMSO) Mass 1 mg 5 mg 10 mg
1 mM 1.1834 mL 5.9171 mL 11.8342 mL
5 mM 0.2367 mL 1.1834 mL 2.3668 mL
10 mM 0.1183 mL 0.5917 mL 1.1834 mL
References
M.Wt

845.01

Formula

C₄₃H₆₅FN₆O₁₀

CAS No.

760981-83-7

Storage
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month
Shipping

Room temperature in continental US; may vary elsewhere

Solvent & Solubility

DMSO: ≥ 32 mg/mL

* "<1 mg/mL" means slightly soluble or insoluble. "≥" means soluble, but saturation unknown.

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number

 

Organization name *

Country *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Solithromycin
Cat. No.:
HY-17593
Quantity: